Last reviewed · How we verify

NCT03139045: VeinGER

Impact of VeinViewer® Vision to Guide Peripheral Venipuncture in Geriatrics

Completed Phase 3 Last updated 18 January 2023
What this trial tests

Phase 3 trial testing Venous puncture in elderly patients in Venipuncture in 200 participants. Completed in 1 December 2021.

Timeline
1 September 2018
Primary endpoint
1 September 2019
1 December 2021

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment200
Start date1 September 2018
Primary completion1 September 2019
Estimated completion1 December 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

75 and older, any sex, with Venipuncture or Geriatric. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Peripheral venipuncture is a common procedure in geriatrics. This procedure due to altered cutaneous alteration and venous capital associated with age poses problems of comfort and quality of life of elderly patients hospitalized. There is little data from the literature that highlights the difficulties of venipuncture in the context of old age. New venous visualization technologies by infrared spectroscopy (NIR) such as VeinViewer® Vision (VVV) have been developed to guide the placement of a peripheral venous (VVP) or venipuncture (PV) route.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Venipuncture

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03139045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing